Today
+0.82%
5 Days
+10.19%
1 Month
-4.96%
6 Months
-3.18%
Year to Date
+9.79%
1 Year
+19.96%
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
** Berenberg raises PT on drugmaker AbbVie ABBV.N to $195 from $165, citing higher immunology drug sales ** New PT is a 8.7% downside to stock's last close** Brokerage says AbbVie knows the autoimmune market well ** Says co reduced exposure to antirheumatic drug Humira and bolstered cash flows t...
Feb 7 (Reuters) - AbbVie ABBV.N said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections, including those caused by drug-resistant bacteria.AbbVie and co-developer Pfizer's PFE.N drug, Emblaveo, is approved in combination with an...
Eli Lilly and Co
Johnson & Johnson
Novartis AG
Novo Nordisk A/S
AstraZeneca PLC
Merck & Co Inc
Amgen Inc
Pfizer Inc
Sanofi SA
Gilead Sciences Inc
Vertex Pharmaceuticals Inc
Bristol-Myers Squibb Co
Haleon PLC
Mckesson Corp
GSK plc
Zoetis Inc
Cardinal Health Inc
Alnylam Pharmaceuticals Inc
Takeda Pharmaceutical Co Ltd
Biogen Inc
